Topic

Texas

A collection of 504 issues

How to Get Poteligeo (mogamulizumab-kpkc) Covered by Aetna CVS Health in Texas: Complete Guide to Prior Authorization, Appeals, and Cost Reduction

Answer Box: Getting Started Aetna CVS Health requires prior authorization for Poteligeo (mogamulizumab-kpkc) in Texas. You'll need documented mycosis fungoides or Sézary syndrome diagnosis, proof of at least one failed prior systemic therapy, and an oncologist's prescription. Submit through the Aetna provider portal or call 1-866-814-5506
6 min read

Coding That Helps Get Cosentyx (secukinumab) Approved in Texas with Aetna CVS Health (ICD-10, HCPCS/J-Code, NDC)

Answer Box: Fastest Path to Cosentyx (secukinumab) Approval in Texas Aetna CVS Health requires prior authorization for Cosentyx (secukinumab) in Texas with specific coding requirements. Use ICD-10 L40.0 (plaque psoriasis), L40.5X (psoriatic arthritis), or M45 (ankylosing spondylitis) with detailed documentation. For IV administration, bill under HCPCS J3247 (effective
6 min read

How to Get Rezlidhia (Olutasidenib) Covered by UnitedHealthcare in Texas: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Rezlidhia Covered in Texas UnitedHealthcare requires prior authorization for Rezlidhia (olutasidenib) in Texas. To get approved, you'll need documented IDH1 mutation testing, confirmed relapsed/refractory AML diagnosis, and evidence of failed prior therapies. Submit through the UnitedHealthcare Provider Portal with complete medical necessity documentation. If
5 min read

Myths vs. Facts: Getting Sylvant (siltuximab) Covered by Cigna in Texas (Complete Guide with Forms and Appeal Scripts)

Answer Box: Getting Sylvant (siltuximab) Covered by Cigna in Texas Eligibility: Cigna covers Sylvant for HIV-negative, HHV-8-negative idiopathic multicentric Castleman disease (iMCD) with prior authorization. Fastest path: Submit complete PA packet with pathology report, negative HIV/HHV-8 labs, and medical necessity letter to Cigna at 855-840-1678. First step today: Contact
5 min read